Raffi Asadorian

Raffi Asadorian has been serving as the Chief Financial Officer of AcelRx Pharmaceuticals, a NASDAQ-listed specialty pharmaceutical company, since August 2017. He brings over three decades of finance experience, including 15 years as a CFO for various biotech and life sciences companies such as Amyris and Barr Pharmaceuticals. Earlier in his career, Asadorian was a Partner in the Transaction Services Group of PwC, LLP in New York. He holds an MBA in Finance from the University of Manchester and a B.Sc. in Business Administration, specializing in Accounting, from Xavier University in Cincinnati. Additionally, he is a Certified Public Accountant, although currently inactive, in Ohio.